 BOSTON, April 28, 2021 GLOBE NEWSWIRE -- Yumanity Therapeutics NASDAQ: YMTX, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that Richard Peters, M.D., Ph.D., President and Chief Executive Officer, will present at the 2021 B. Riley Securities Neuroscience Conference. 